Tony Michael Argenbright

Array ( [id] => 7288570 [patent_doc_number] => 20040147600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Pharmaceutical combination comprising either (s)-2-ethoxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy)phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl)ethoxy]phenyl}-(s-2ethoxy propanoic acid and insulin' [patent_app_type] => new [patent_app_number] => 10/479707 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5586 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147600.pdf [firstpage_image] =>[orig_patent_app_number] => 10479707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705899 [patent_doc_number] => 20060194947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Peptide gap junction modulators' [patent_app_type] => utility [patent_app_number] => 10/534201 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18592 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194947.pdf [firstpage_image] =>[orig_patent_app_number] => 10534201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674701 [patent_doc_number] => 20040127417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'N-terminally monopegylated human growth hormone conjugates and process for their preparation' [patent_app_type] => new [patent_app_number] => 10/718340 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10386 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127417.pdf [firstpage_image] =>[orig_patent_app_number] => 10718340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4477272 [patent_doc_number] => 07906477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Activation of peptide prodrugs by hK2' [patent_app_type] => utility [patent_app_number] => 10/535351 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11657 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906477.pdf [firstpage_image] =>[orig_patent_app_number] => 10535351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432320 [patent_doc_number] => 07265093 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'Drug therapy for Celiac Sprue' [patent_app_type] => utility [patent_app_number] => 10/716846 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10131 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/265/07265093.pdf [firstpage_image] =>[orig_patent_app_number] => 10716846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 545942 [patent_doc_number] => 07164008 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-16 [patent_title] => 'Isolated complexes of endotoxin and MD-2' [patent_app_type] => utility [patent_app_number] => 10/715876 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18525 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/164/07164008.pdf [firstpage_image] =>[orig_patent_app_number] => 10715876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 285496 [patent_doc_number] => 07550423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Somatostatin antagonists' [patent_app_type] => utility [patent_app_number] => 10/712081 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11021 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550423.pdf [firstpage_image] =>[orig_patent_app_number] => 10712081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7215907 [patent_doc_number] => 20040071650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Use of cyclosporin 7-thioamide derivatives for hair growth' [patent_app_type] => new [patent_app_number] => 10/432451 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6913 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20040071650.pdf [firstpage_image] =>[orig_patent_app_number] => 10432451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141264 [patent_doc_number] => 20070003480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Liposomal composition comprising haptotactic peptides' [patent_app_type] => utility [patent_app_number] => 10/533826 [patent_app_country] => US [patent_app_date] => 2003-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9297 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003480.pdf [firstpage_image] =>[orig_patent_app_number] => 10533826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083813 [patent_doc_number] => 20050049193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Leptin-related peptides' [patent_app_type] => utility [patent_app_number] => 10/698510 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 38629 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049193.pdf [firstpage_image] =>[orig_patent_app_number] => 10698510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851729 [patent_doc_number] => 20060234920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'New antitumoral compounds' [patent_app_type] => utility [patent_app_number] => 10/531533 [patent_app_country] => US [patent_app_date] => 2003-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6706 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234920.pdf [firstpage_image] =>[orig_patent_app_number] => 10531533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1053375 [patent_doc_number] => 06858705 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-22 [patent_title] => 'Stable radioiodine conjugates and methods for their synthesis' [patent_app_type] => utility [patent_app_number] => 10/686436 [patent_app_country] => US [patent_app_date] => 2003-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12546 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858705.pdf [firstpage_image] =>[orig_patent_app_number] => 10686436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 817137 [patent_doc_number] => 07410945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-12 [patent_title] => 'Treatment of inflammatory bowel disease' [patent_app_type] => utility [patent_app_number] => 10/531564 [patent_app_country] => US [patent_app_date] => 2003-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11530 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/410/07410945.pdf [firstpage_image] =>[orig_patent_app_number] => 10531564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649698 [patent_doc_number] => 20060135433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Phenolic binding peptides' [patent_app_type] => utility [patent_app_number] => 10/528514 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11051 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135433.pdf [firstpage_image] =>[orig_patent_app_number] => 10528514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 830272 [patent_doc_number] => 07399826 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-07-15 [patent_title] => 'Peptide for promoting healing of fractures' [patent_app_type] => utility [patent_app_number] => 10/577739 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2700 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399826.pdf [firstpage_image] =>[orig_patent_app_number] => 10577739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726460 [patent_doc_number] => 20060057220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Fine spherical particles with satisfactory molecular orientation, spherical microcapsules comprising the same and processes for producing these' [patent_app_type] => utility [patent_app_number] => 10/530198 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3583 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057220.pdf [firstpage_image] =>[orig_patent_app_number] => 10530198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5608074 [patent_doc_number] => 20060269590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Enzyme-sensitive therapeutic wound dressings' [patent_app_type] => utility [patent_app_number] => 10/529157 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5422 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269590.pdf [firstpage_image] =>[orig_patent_app_number] => 10529157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 150853 [patent_doc_number] => 07682631 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-23 [patent_title] => 'Adhesin-specific nanoparticles and process for using same' [patent_app_type] => utility [patent_app_number] => 10/677132 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 11866 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/682/07682631.pdf [firstpage_image] =>[orig_patent_app_number] => 10677132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5100759 [patent_doc_number] => 20070184021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Use of caspase inhibitors as a therapeutic agent against radiation-induced injury' [patent_app_type] => utility [patent_app_number] => 10/529661 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16611 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184021.pdf [firstpage_image] =>[orig_patent_app_number] => 10529661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5922480 [patent_doc_number] => 20060240510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Method for designing peptides' [patent_app_type] => utility [patent_app_number] => 10/528989 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8108 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240510.pdf [firstpage_image] =>[orig_patent_app_number] => 10528989 [rel_patent_id] =>[rel_patent_doc_number] =>)